Affordable Access

Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumors.

Authors
Type
Published Article
Journal
Journal of hematotherapy & stem cell research
Publication Date
Volume
10
Issue
2
Pages
247–260
Identifiers
PMID: 11359672
Source
Medline

Abstract

Statistics

Seen <100 times